|
|
Volumn 6, Issue 2, 1999, Pages 136-145
|
|
Trends in cancer pain management
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
BACLOFEN;
CALCITONIN;
CAPSAICIN;
CLONIDINE;
CORTICOSTEROID;
DEXTROMETHORPHAN;
FENTANYL;
HYDROMORPHONE;
KETAMINE;
LEVORPHANOL;
METHADONE;
MEXILETINE;
MORPHINE;
NEUROLEPTIC AGENT;
OCTREOTIDE;
OXYCODONE;
OXYMORPHONE;
PAMIDRONIC ACID;
PHENOXYBENZAMINE;
PRAZOSIN;
SAMARIUM 153;
SCOPOLAMINE;
STRONTIUM 89;
TIZANIDINE;
TOCAINIDE;
ANALGESIA;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER PAIN;
CANCER PALLIATIVE THERAPY;
CANCER PATIENT;
CLINICAL PROTOCOL;
CONTROLLED RELEASE FORMULATION;
DRUG HALF LIFE;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
NERVE STIMULATION;
ORAL DRUG ADMINISTRATION;
PATIENT MONITORING;
PRACTICE GUIDELINE;
PSYCHOLOGICAL ASPECT;
RECTAL DRUG ADMINISTRATION;
SUBCUTANEOUS DRUG ADMINISTRATION;
TERMINAL CARE;
TREATMENT OUTCOME;
WORLD HEALTH ORGANIZATION;
|
|
EID: 0032899766
PISSN: 10732748
EISSN: None
Source Type: Journal
DOI: 10.1177/107327489900600202 Document Type: Article |
|
Times cited : (42)
|
|
References (36)
|
